RareSearch logo

Seattle Children's Hospital Research Institute - Center for Global Infectious Disease Research

50+ personnel
Headquartered in Chandler
Established in 2025
Website
Christie Cassin profile

Christie Cassin

πŸ‡ΈπŸ‡¦ Saudi Arabia

8.8

    Reviewed:

  • - Companion Diagnostics Development
  • - 16 weeks January - May 2024
  • - Pharmaceutical Company

High-quality companion diagnostics development, delivered on time.

The development of companion diagnostics was of high quality, and the project was delivered on time. The team's technical expertise and understanding of the regulatory environment were key to the success of the project.

Annette Beier profile

Annette Beier

πŸ‡°πŸ‡· South Korea

6.3

    Reviewed:

  • - Stability Studies
  • - 16 months July 2023 - November 2024
  • - Pharmaceutical Company

Stability studies lacked detail, required additional validation.

The stability studies conducted were lacking in detail, and we had to perform additional validation to ensure the results were reliable. This added extra time and cost to the project. The team was responsive to feedback, but the initial work was subpar.

Shirley Kub Jr. profile

Shirley Kub Jr.

πŸ‡°πŸ‡· South Korea

5.4

    Reviewed:

  • - Process Development
  • - 14 weeks June - September 2024
  • - Biotech Company

Process development project faced delays, communication issues.

The process development project encountered multiple delays, and communication was inconsistent. We had to extend our project timeline due to the setbacks, and this impacted our overall production schedule. The team was capable but seemed overextended.

Rickey Cummerata profile

Rickey Cummerata

πŸ‡¬πŸ‡§ United Kingdom

6

    Reviewed:

  • - Health Technology Assessment
  • - 8 weeks July - September 2024
  • - Pharmaceutical Company

Health technology assessment was superficial, lacked thorough analysis.

The health technology assessment (HTA) was superficial and did not provide the level of thorough analysis we needed. Some important factors were overlooked, and we had to request additional work to cover these gaps. The overall experience was disappointing.

Richard Dicki profile

Richard Dicki

πŸ‡¨πŸ‡³ China

9.4

    Reviewed:

  • - Health Technology Assessment
  • - 10 weeks September - November 2023
  • - Pharmaceutical Company

Thorough and insightful health technology assessment.

The health technology assessment was thorough and provided valuable insights that were critical to our decision-making process. The team demonstrated a deep understanding of the health economics involved and delivered a well-rounded analysis.